Shau Yu Lynch Selected Research

Low Back Pain (Lumbago)

4/2016	A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression.
3/2016	Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials.
1/2015	Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain.
1/2015	A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain.
12/2014	The impact of buprenorphine transdermal delivery system on activities of daily living among patients with chronic low back pain: an application of the international classification of functioning, disability and health.
2/2013	Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain.
1/2013	A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shau Yu Lynch Research Topics

Disease

8	Pain (Aches) 01/2017 - 01/2013
7	Low Back Pain (Lumbago) 04/2016 - 01/2013
6	Chronic Pain 01/2017 - 05/2013
1	Ototoxicity 01/2017
1	Deafness (Deaf Mutism) 01/2017
1	Sensorineural Hearing Loss 01/2017
1	Fatigue 07/2015
1	Sleepiness 07/2015
1	Constipation 07/2015
1	Dizziness (Lightheadedness) 07/2015
1	Headache (Headaches) 07/2015
1	Nausea 07/2015
1	Vomiting 07/2015

Drug/Important Bio-Agent (IBA)

9	Opioid Analgesics (Opioids)IBA 01/2017 - 01/2013
7	Buprenorphine (Subutex)FDA LinkGeneric 04/2016 - 01/2013
6	Hydrocodone (Dihydrocodeinone)FDA LinkGeneric 01/2017 - 01/2015
4	TabletsIBA 01/2017 - 01/2015
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017
1	Morphine (MS Contin)FDA LinkGeneric 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	ORALIT (ORS)IBA 12/2014
1	Pharmaceutical PreparationsIBA 05/2013

Therapy/Procedure

2	Activities of Daily Living (ADL) 07/2015 - 12/2014
1	Pain Management 01/2017